 Sunad Rangarajan
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 10 | 2023 | 634 | 2.890 |
Why?
| | Myofibroblasts | 7 | 2022 | 121 | 1.470 |
Why?
| | Energy Metabolism | 3 | 2024 | 875 | 1.240 |
Why?
| | Fibroblasts | 4 | 2024 | 954 | 0.940 |
Why?
| | Indoles | 3 | 2017 | 387 | 0.920 |
Why?
| | Glycolysis | 2 | 2024 | 314 | 0.800 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 8 | 0.800 |
Why?
| | Lung | 9 | 2022 | 3940 | 0.730 |
Why?
| | Bone Marrow | 1 | 2019 | 272 | 0.580 |
Why?
| | Pyridones | 2 | 2017 | 158 | 0.570 |
Why?
| | Aging | 2 | 2017 | 1774 | 0.520 |
Why?
| | Pulmonary Fibrosis | 2 | 2019 | 385 | 0.520 |
Why?
| | Fibrosis | 4 | 2023 | 526 | 0.500 |
Why?
| | Mitochondria | 3 | 2018 | 875 | 0.480 |
Why?
| | Metformin | 1 | 2018 | 316 | 0.450 |
Why?
| | Transforming Growth Factor beta1 | 6 | 2020 | 158 | 0.440 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 391 | 0.400 |
Why?
| | Restless Legs Syndrome | 2 | 2007 | 21 | 0.340 |
Why?
| | Fibronectins | 2 | 2020 | 127 | 0.280 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2007 | 59 | 0.260 |
Why?
| | Smad3 Protein | 2 | 2016 | 43 | 0.250 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2016 | 277 | 0.250 |
Why?
| | Cells, Cultured | 4 | 2023 | 4102 | 0.240 |
Why?
| | Developing Countries | 1 | 2007 | 284 | 0.230 |
Why?
| | Oxidative Stress | 2 | 2022 | 1264 | 0.230 |
Why?
| | Cellular Senescence | 1 | 2023 | 173 | 0.190 |
Why?
| | Humans | 18 | 2024 | 129847 | 0.190 |
Why?
| | Sirtuin 3 | 1 | 2021 | 58 | 0.170 |
Why?
| | Peptide Hydrolases | 1 | 2020 | 108 | 0.160 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 592 | 0.160 |
Why?
| | Interleukin-33 | 1 | 2019 | 48 | 0.160 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2016 | 56 | 0.150 |
Why?
| | Adenylate Kinase | 1 | 2018 | 26 | 0.150 |
Why?
| | Bone Marrow Cells | 1 | 2019 | 302 | 0.150 |
Why?
| | Animals | 6 | 2024 | 35409 | 0.150 |
Why?
| | Mice | 3 | 2024 | 16983 | 0.140 |
Why?
| | Signal Transduction | 4 | 2019 | 4935 | 0.140 |
Why?
| | RNA Interference | 2 | 2016 | 451 | 0.140 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 144 | 0.140 |
Why?
| | Bleomycin | 1 | 2018 | 243 | 0.130 |
Why?
| | Alveolar Epithelial Cells | 1 | 2017 | 107 | 0.130 |
Why?
| | Enzyme Activation | 1 | 2018 | 813 | 0.130 |
Why?
| | Cysteine-Rich Protein 61 | 1 | 2016 | 5 | 0.130 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2016 | 6 | 0.130 |
Why?
| | Beclin-1 | 1 | 2016 | 11 | 0.130 |
Why?
| | Spheroids, Cellular | 1 | 2017 | 76 | 0.130 |
Why?
| | Ubiquitin-Activating Enzymes | 1 | 2016 | 16 | 0.130 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2016 | 72 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2016 | 95 | 0.120 |
Why?
| | Cell Movement | 1 | 2020 | 950 | 0.120 |
Why?
| | Drug Approval | 1 | 2016 | 87 | 0.120 |
Why?
| | Collagen Type I | 1 | 2016 | 118 | 0.120 |
Why?
| | Caveolin 1 | 1 | 2015 | 19 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 182 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 340 | 0.110 |
Why?
| | Transfection | 1 | 2016 | 918 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2017 | 827 | 0.100 |
Why?
| | Lung Injury | 1 | 2016 | 211 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 314 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5468 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2016 | 0.090 |
Why?
| | Phosphorylation | 1 | 2016 | 1716 | 0.090 |
Why?
| | India | 2 | 2007 | 171 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2016 | 1119 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2016 | 2703 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2018 | 4077 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2015 | 1900 | 0.070 |
Why?
| | Protoporphyrins | 1 | 2007 | 16 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2015 | 2378 | 0.070 |
Why?
| | Iron-Binding Proteins | 1 | 2007 | 40 | 0.070 |
Why?
| | Menorrhagia | 1 | 2007 | 20 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2545 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2007 | 306 | 0.060 |
Why?
| | Blood Donors | 1 | 2007 | 97 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 796 | 0.060 |
Why?
| | Time Factors | 1 | 2016 | 6550 | 0.060 |
Why?
| | Urban Population | 1 | 2007 | 443 | 0.060 |
Why?
| | Aged | 1 | 2022 | 22107 | 0.050 |
Why?
| | Up-Regulation | 2 | 2016 | 836 | 0.050 |
Why?
| | Cell Line | 2 | 2020 | 2780 | 0.050 |
Why?
| | Erythrocytes | 1 | 2007 | 673 | 0.050 |
Why?
| | A549 Cells | 1 | 2020 | 59 | 0.040 |
Why?
| | Peroxidase | 1 | 2020 | 175 | 0.040 |
Why?
| | Tyrosine | 1 | 2020 | 223 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2020 | 207 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2007 | 2739 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2007 | 5085 | 0.040 |
Why?
| | Disease Progression | 2 | 2017 | 2628 | 0.040 |
Why?
| | Male | 3 | 2018 | 63759 | 0.040 |
Why?
| | Genes, Developmental | 1 | 2016 | 2 | 0.030 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2016 | 23 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1031 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2020 | 508 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1465 | 0.030 |
Why?
| | Hedgehog Proteins | 1 | 2016 | 188 | 0.030 |
Why?
| | Electron Transport | 1 | 2015 | 112 | 0.030 |
Why?
| | Smad Proteins | 1 | 2015 | 40 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 317 | 0.030 |
Why?
| | Neutrophils | 1 | 2020 | 1209 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 280 | 0.030 |
Why?
| | Down-Regulation | 1 | 2016 | 631 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2016 | 462 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2016 | 646 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 2888 | 0.030 |
Why?
| | Biopsy | 1 | 2017 | 1089 | 0.030 |
Why?
| | Precision Medicine | 1 | 2017 | 385 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1690 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2015 | 672 | 0.020 |
Why?
| | Cell Survival | 1 | 2015 | 1086 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1686 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1724 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3384 | 0.020 |
Why?
| | Middle Aged | 2 | 2007 | 31177 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3089 | 0.020 |
Why?
| | Female | 3 | 2020 | 68829 | 0.020 |
Why?
| | Adult | 2 | 2007 | 35634 | 0.020 |
Why?
| | Research Design | 1 | 2007 | 1045 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2564 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 5437 | 0.010 |
Why?
|
|
Rangarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|